new study showing coenzyme Q10 might slow progression of Parkinson's disease

November 2002

Patients are asking about the new study showing coenzyme Q10 might slow progression of Parkinson's disease.

Researchers suspect that coenzyme Q10 improves energy production in the mitochondria. Parkinson's patients seem to have lower levels of CoQ10 and reduced mitochondrial function.

CoQ10 is also a potent antioxidant that might protect brain cells.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote